{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:13:38Z","timestamp":1790201618556,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010470","name":"Gillson Longenbaugh Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tau aggregates propagate in brain cells and transmit to neighboring cells as well as anatomically connected brain regions by prion-like mechanisms. Soluble tau aggregates (tau oligomers) are the most toxic species that initiate neurodegeneration in tauopathies, such as Alzheimer\u2019s disease (AD), progressive supranuclear palsy (PSP), and dementia with Lewy bodies (DLB). Exogenous tau aggregates have been shown to be internalized by brain cells; however, the precise cellular and molecular mechanisms that underlie the internalization of tau oligomers (TauO) remain elusive. Using brain-derived tau oligomers (BDTOs) from AD, PSP, and DLB patients, we investigated neuronal internalization mechanisms of BDTOs, including the heparan sulfate proteoglycan (HSPG)-mediated pathway, clathrin-mediated pathway, and caveolae-mediated pathway. Here, we demonstrated that the HSPG-mediated pathway regulates internalization of BDTOs from AD and DLB, while HSPG-mediated and other alternative pathways are involved in the internalization of PSP-derived tau oligomers. HSPG antagonism significantly reduced the internalization of TauO, prevented tau translocation to the endosomal\u2013lysosomal system, and decreased levels of hyperphosphorylated tau in neurons, the well-known contributor for neurofibrillary tangles (NFT) accumulation, degeneration of neurons, and cognitive decline. Furthermore, siRNA-mediated silencing of heparan sulfate (HS)-synthesizing enzyme, exostosin-2, leads to decreased internalization of BDTOs, prevented tau-induced autophagy\u2013lysosomal pathway impairment, and decreased hyperphosphorylated tau levels. Collectively, these findings suggest that HSPG-mediated endocytosis and exostsin-2 are involved in neuronal internalization of TauO and subsequent tau-dependent neuropathology in AD and DLB.<\/jats:p>","DOI":"10.1038\/s41419-020-2503-3","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T08:04:13Z","timestamp":1588579453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer\u2019s disease, progressive supranuclear palsy and dementia with Lewy bodies"],"prefix":"10.1038","volume":"11","author":[{"given":"Nicha","family":"Puangmalai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemil","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0456-452X","authenticated-orcid":false,"given":"Mauro","family":"Montalbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmi","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-1357","authenticated-orcid":false,"given":"Sagar","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"McAllen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ellsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakez","family":"Kayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"2503_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","volume":"1","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1, 213\u2013216 (1991).","journal-title":"Brain Pathol."},{"key":"2503_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2051-5960-2-14","volume":"2","author":"S Dujardin","year":"2014","unstructured":"Dujardin, S. et al. Neuron-to-neuron wild-type tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathol. Commun. 2, 14 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"2503_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7, e31302 (2012).","journal-title":"PLoS ONE"},{"key":"2503_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman, S. K. et al. Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92, 796\u2013812 (2016).","journal-title":"Neuron"},{"key":"2503_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","volume":"83","author":"D Xu","year":"2014","unstructured":"Xu, D. & Esko, J. D. Demystifying heparan sulfate-protein interactions. Annu. Rev. Biochem 83, 129\u2013157 (2014).","journal-title":"Annu. Rev. Biochem"},{"key":"2503_CR6","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes, B. B. et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl Acad. Sci. USA 110, E3138\u2013E3147 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2503_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08720-5","volume":"7","author":"E Ihse","year":"2017","unstructured":"Ihse, E. et al. Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type. Sci. Rep. 7, 9008 (2017).","journal-title":"Sci. Rep."},{"key":"2503_CR8","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1523\/JNEUROSCI.5491-10.2011","volume":"31","author":"T Kanekiyo","year":"2011","unstructured":"Kanekiyo, T. et al. Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J. Neurosci. 31, 1644\u20131651 (2011).","journal-title":"J. Neurosci."},{"key":"2503_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.bpj.2017.01.024","volume":"112","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. Glycan determinants of heparin-tau interaction. Biophys. J. 112, 921\u2013932 (2017).","journal-title":"Biophys. J."},{"key":"2503_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0165-3806(03)00010-5","volume":"141","author":"M Inatani","year":"2003","unstructured":"Inatani, M. & Yamaguchi, Y. Gene expression of EXT1 and EXT2 during mouse brain development. Brain Res Dev. Brain Res. 141, 129\u2013136 (2003).","journal-title":"Brain Res Dev. Brain Res."},{"key":"2503_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3740","volume":"4","author":"K Takeuchi","year":"2013","unstructured":"Takeuchi, K. et al. Chondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injury. Nat. Commun. 4, 2740 (2013).","journal-title":"Nat. Commun."},{"key":"2503_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24904-z","volume":"8","author":"JN Rauch","year":"2018","unstructured":"Rauch, J. N. et al. Tau internalization is regulated by 6-O sulfation on heparan sulfate proteoglycans (HSPGs). Sci. Rep. 8, 6382 (2018).","journal-title":"Sci. Rep."},{"key":"2503_CR13","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1074\/jbc.RA117.000378","volume":"293","author":"BE Stopschinski","year":"2018","unstructured":"Stopschinski, B. E. et al. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus alpha-synuclein and beta-amyloid aggregates. J. Biol. Chem. 293, 10826\u201310840 (2018).","journal-title":"J. Biol. Chem."},{"key":"2503_CR14","doi-asserted-by":"publisher","first-page":"22122","DOI":"10.1074\/jbc.M111.236257","volume":"286","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves, C. A., Glabe, C. G. & Kayed, R. Amyloid-beta annular protofibrils evade fibrillar fate in Alzheimer disease brain. J. Biol. Chem. 286, 22122\u201322130 (2011).","journal-title":"J. Biol. Chem."},{"key":"2503_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep00700","volume":"2","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves, C. A. et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci. Rep. 2, 700 (2012).","journal-title":"Sci. Rep."},{"key":"2503_CR16","doi-asserted-by":"publisher","first-page":"23063","DOI":"10.1074\/jbc.M111.237974","volume":"286","author":"KR Patterson","year":"2011","unstructured":"Patterson, K. R. et al. Characterization of prefibrillar tau oligomers in vitro and in Alzheimer disease. J. Biol. Chem. 286, 23063\u201323076 (2011).","journal-title":"J. Biol. Chem."},{"key":"2503_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4939-7816-8_9","volume":"1779","author":"U Sengupta","year":"2018","unstructured":"Sengupta, U., Carretero-Murillo, M. & Kayed, R. Preparation and characterization of Tau oligomer strains. Methods Mol. Biol. 1779, 113\u2013146 (2018).","journal-title":"Methods Mol. Biol."},{"key":"2503_CR18","doi-asserted-by":"publisher","first-page":"10039","DOI":"10.1021\/bi1016233","volume":"49","author":"CA Lasagna-Reeves","year":"2010","unstructured":"Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Guerrero-Muoz, M. J., Jackson, G. R. & Kayed, R. Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49, 10039\u201310041 (2010).","journal-title":"Biochemistry"},{"key":"2503_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/2051-5960-2-73","volume":"2","author":"JE Gerson","year":"2014","unstructured":"Gerson, J. E. et al. Characterization of tau oligomeric seeds in progressive supranuclear palsy. Acta Neuropathol. Commun. 2, 73 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"2503_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2051-5960-2-56","volume":"2","author":"CA Lasagna-Reeves","year":"2014","unstructured":"Lasagna-Reeves, C. A. et al. The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes. Acta Neuropathol. Commun. 2, 56 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"2503_CR21","doi-asserted-by":"publisher","first-page":"19011","DOI":"10.1038\/s41598-019-55419-w","volume":"9","author":"F Lo Cascio","year":"2019","unstructured":"Lo Cascio, F. et al. Toxic tau oligomers modulated by novel curcumin derivatives. Sci. Rep. 9, 19011\u201319011 (2019).","journal-title":"Sci. Rep."},{"key":"2503_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fnins.2019.00442","volume":"13","author":"JR Perea","year":"2019","unstructured":"Perea, J. R. et al. Extracellular monomeric tau is internalized by astrocytes. Front. Neurosci. 13, 442 (2019).","journal-title":"Front. Neurosci."},{"key":"2503_CR23","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","volume":"35","author":"M Usenovic","year":"2015","unstructured":"Usenovic, M. et al. Internalized tau oligomers cause neurodegeneration by inducing accumulation of pathogenic tau in human neurons derived from induced pluripotent stem cells. J. Neurosci. 35, 14234\u201314250 (2015).","journal-title":"J. Neurosci."},{"key":"2503_CR24","doi-asserted-by":"crossref","unstructured":"Wauters, M., Wattiez, R. & Ris, L. Internalization of the extracellular full-length tau inside Neuro2A and cortical cells is enhanced by phosphorylation. Biomolecules 6, 36 (2016).","DOI":"10.3390\/biom6030036"},{"key":"2503_CR25","doi-asserted-by":"publisher","first-page":"11833","DOI":"10.1128\/JVI.00857-06","volume":"80","author":"J Xie","year":"2006","unstructured":"Xie, J. et al. Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini. J. Virol. 80, 11833\u201311851 (2006).","journal-title":"J. Virol."},{"key":"2503_CR26","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1021\/acschemneuro.7b00501","volume":"9","author":"F Lo Cascio","year":"2018","unstructured":"Lo Cascio, F. & Kayed, R. Azure C targets and modulates toxic tau oligomers. ACS Chem. Neurosci. 9, 1317\u20131326 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"2503_CR27","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1074\/jbc.M112.394528","volume":"288","author":"JW Wu","year":"2013","unstructured":"Wu, J. W. et al. Small misfolded tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J. Biol. Chem. 288, 1856\u20131870 (2013).","journal-title":"J. Biol. Chem."},{"key":"2503_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15295","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou, L. et al. Tau association with synaptic vesicles causes presynaptic dysfunction. Nat. Commun. 8, 15295 (2017).","journal-title":"Nat. Commun."},{"key":"2503_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-9-39","volume":"9","author":"TE Hansen","year":"2011","unstructured":"Hansen, T. E. & Johansen, T. Following autophagy step by step. BMC Biol. 9, 39 (2011).","journal-title":"BMC Biol."},{"key":"2503_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27\u201342 (2008).","journal-title":"Cell"},{"key":"2503_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36379-z","volume":"9","author":"J Adams","year":"2019","unstructured":"Adams, J. et al. Autophagy-lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease. Sci. Rep. 9, 151 (2019).","journal-title":"Sci. Rep."},{"key":"2503_CR32","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1523\/JNEUROSCI.3498-17.2019","volume":"39","author":"LP Elia","year":"2019","unstructured":"Elia, L. P., Mason, A. R., Alijagic, A. & Finkbeiner, S. Genetic regulation of neuronal progranulin reveals a critical role for the autophagy-lysosome pathway. J. Neurosci. 39, 3332\u20133344 (2019).","journal-title":"J. Neurosci."},{"key":"2503_CR33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ana.25351","volume":"84","author":"KA Metz","year":"2018","unstructured":"Metz, K. A. et al. KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect. Ann. Neurol. 84, 766\u2013780 (2018).","journal-title":"Ann. Neurol."},{"key":"2503_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1042\/EBC20160005","volume":"60","author":"MP Jackson","year":"2016","unstructured":"Jackson, M. P. & Hewitt, E. W. Cellular proteostasis: degradation of misfolded proteins by lysosomes. Essays Biochem 60, 173\u2013180 (2016).","journal-title":"Essays Biochem"},{"key":"2503_CR35","doi-asserted-by":"crossref","unstructured":"Thellung, S., Corsaro, A., Nizzari, M., Barbieri, F. & Florio, T. Autophagy activator drugs: a new opportunity in neuroprotection from misfolded protein toxicity. Int. J. Mol. Sci. 20, 901 (2019).","DOI":"10.3390\/ijms20040901"},{"key":"2503_CR36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/mp.2016.139","volume":"22","author":"A Caccamo","year":"2017","unstructured":"Caccamo, A., Ferreira, E., Branca, C. & Oddo, S. p62 improves AD-like pathology by increasing autophagy. Mol. Psychiatry 22, 865\u2013873 (2017).","journal-title":"Mol. Psychiatry"},{"key":"2503_CR37","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost, B., Jacks, R. L. & Diamond, M. I. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845\u201312852 (2009).","journal-title":"J. Biol. Chem."},{"key":"2503_CR38","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders, D. W. et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271\u20131288 (2014).","journal-title":"Neuron"},{"key":"2503_CR39","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/pro.3499","volume":"27","author":"G Ghag","year":"2018","unstructured":"Ghag, G. et al. Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior. Protein Sci. 27, 1901\u20131909 (2018).","journal-title":"Protein Sci."},{"key":"2503_CR40","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1073\/pnas.1017275108","volume":"108","author":"C Munch","year":"2011","unstructured":"Munch, C., O\u2019Brien, J. & Bertolotti, A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl Acad. Sci. USA 108, 3548\u20133553 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2503_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02227-9","volume":"7","author":"E Wesen","year":"2017","unstructured":"Wesen, E., Jeffries, G. D. M., Matson Dzebo, M. & Esbjorner, E. K. Endocytic uptake of monomeric amyloid-beta peptides is clathrin- and dynamin-independent and results in selective accumulation of Abeta(1-42) compared to Abeta(1-40). Sci. Rep. 7, 2021 (2017).","journal-title":"Sci. Rep."},{"key":"2503_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fphys.2015.00277","volume":"6","author":"R Zeineddine","year":"2015","unstructured":"Zeineddine, R. & Yerbury, J. J. The role of macropinocytosis in the propagation of protein aggregation associated with neurodegenerative diseases. Front. Physiol. 6, 277 (2015).","journal-title":"Front. Physiol."},{"key":"2503_CR43","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1016\/j.celrep.2018.03.021","volume":"22","author":"LD Evans","year":"2018","unstructured":"Evans, L. D. et al. Extracellular monomeric and aggregated tau efficiently enter human neurons through overlapping but distinct pathways. Cell Rep. 22, 3612\u20133624 (2018).","journal-title":"Cell Rep."},{"key":"2503_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1515\/revneuro-2014-0076","volume":"26","author":"A Zare-Shahabadi","year":"2015","unstructured":"Zare-Shahabadi, A., Masliah, E., Johnson, G. V. & Rezaei, N. Autophagy in Alzheimer\u2019s disease. Rev. Neurosci. 26, 385\u2013395 (2015).","journal-title":"Rev. Neurosci."},{"key":"2503_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12017-013-8269-3","volume":"16","author":"A Armstrong","year":"2014","unstructured":"Armstrong, A. et al. Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer\u2019s disease. Neuromolecular Med. 16, 150\u2013160 (2014).","journal-title":"Neuromolecular Med."},{"key":"2503_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuroscience.2014.01.001","volume":"263","author":"EE Coffey","year":"2014","unstructured":"Coffey, E. E., Beckel, J. M., Laties, A. M. & Mitchell, C. H. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer\u2019s disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience 263, 111\u2013124 (2014).","journal-title":"Neuroscience"},{"key":"2503_CR47","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/clinchem\/44.10.2094","volume":"44","author":"CT Hua","year":"1998","unstructured":"Hua, C. T., Hopwood, J. J., Carlsson, S. R., Harris, R. J. & Meikle, P. J. Evaluation of the lysosome-associated membrane protein LAMP-2 as a marker for lysosomal storage disorders. Clin. Chem. 44, 2094\u20132102 (1998).","journal-title":"Clin. Chem."},{"key":"2503_CR48","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1074\/jbc.M114.589309","volume":"290","author":"B Falcon","year":"2015","unstructured":"Falcon, B. et al. Conformation determines the seeding potencies of native and recombinant tau aggregates. J. Biol. Chem. 290, 1049\u20131065 (2015).","journal-title":"J. Biol. Chem."},{"key":"2503_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-015-1507-z","volume":"131","author":"J Lewis","year":"2016","unstructured":"Lewis, J. & Dickson, D. W. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 131, 27\u201348 (2016).","journal-title":"Acta Neuropathol."},{"key":"2503_CR50","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/mds.27198","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga, S. et al. Cognitive impairment in progressive supranuclear palsy is associated with tau burden. Mov. Disord. 32, 1772\u20131779 (2017).","journal-title":"Mov. Disord."},{"key":"2503_CR51","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/bpa.12214","volume":"25","author":"K Tanji","year":"2015","unstructured":"Tanji, K. et al. p62 deficiency enhances alpha-Synuclein pathology in mice. Brain Pathol. 25, 552\u2013564 (2015).","journal-title":"Brain Pathol."},{"key":"2503_CR52","doi-asserted-by":"publisher","first-page":"9034","DOI":"10.1073\/pnas.1530287100","volume":"100","author":"J Berriman","year":"2003","unstructured":"Berriman, J. et al. Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure. Proc. Natl Acad. Sci. USA 100, 9034\u20139038 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2503_CR53","doi-asserted-by":"publisher","first-page":"48165","DOI":"10.1074\/jbc.M105196200","volume":"276","author":"M von Bergen","year":"2001","unstructured":"von Bergen, M. et al. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J. Biol. Chem. 276, 48165\u201348174 (2001).","journal-title":"J. Biol. Chem."},{"key":"2503_CR54","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer\u2019s and Pick\u2019s diseases. eLife 8, e43584 (2019).","DOI":"10.7554\/eLife.43584"},{"key":"2503_CR55","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bcp.2013.12.023","volume":"88","author":"MJ Guerrero-Munoz","year":"2014","unstructured":"Guerrero-Munoz, M. J., Castillo-Carranza, D. L. & Kayed, R. Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins. Biochem. Pharm. 88, 468\u2013478 (2014).","journal-title":"Biochem. Pharm."},{"key":"2503_CR56","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","volume":"78","author":"U Sengupta","year":"2015","unstructured":"Sengupta, U. et al. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies. Biol. Psychiatry 78, 672\u2013683 (2015).","journal-title":"Biol. Psychiatry"},{"key":"2503_CR57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1440-1789.2006.00669.x","volume":"26","author":"K Arima","year":"2006","unstructured":"Arima, K. Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 26, 475\u2013483 (2006).","journal-title":"Neuropathology"},{"key":"2503_CR58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40478-018-0637-7","volume":"6","author":"S Dujardin","year":"2018","unstructured":"Dujardin, S. et al. Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathol. Commun. 6, 132 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"2503_CR59","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fncel.2019.00296","volume":"13","author":"TK Karikari","year":"2019","unstructured":"Karikari, T. K. et al. Distinct conformations, aggregation and cellular internalization of different tau strains. Front. Cell Neurosci. 13, 296 (2019).","journal-title":"Front. Cell Neurosci."},{"key":"2503_CR60","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/nature05817","volume":"446","author":"JR Bishop","year":"2007","unstructured":"Bishop, J. R., Schuksz, M. & Esko, J. D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030\u20131037 (2007).","journal-title":"Nature"},{"key":"2503_CR61","doi-asserted-by":"publisher","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","volume":"33","author":"T Kanekiyo","year":"2013","unstructured":"Kanekiyo, T. et al. Neuronal clearance of amyloid-beta by endocytic receptor LRP1. J. Neurosci. 33, 19276\u201319283 (2013).","journal-title":"J. Neurosci."},{"key":"2503_CR62","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo, T., Xu, H. & Bu, G. ApoE and Abeta in Alzheimer\u2019s disease: accidental encounters or partners? Neuron 81, 740\u2013754 (2014).","journal-title":"Neuron"},{"key":"2503_CR63","first-page":"332ra344","volume":"8","author":"CC Liu","year":"2016","unstructured":"Liu, C. C. et al. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-beta clearance and aggregation in Alzheimer\u2019s disease. Sci. Transl. Med 8, 332ra344 (2016).","journal-title":"Sci. Transl. Med"},{"key":"2503_CR64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/13554790802632967","volume":"15","author":"J Narvid","year":"2009","unstructured":"Narvid, J. et al. Of brain and bone: the unusual case of Dr. A. Neurocase 15, 190\u2013205 (2009).","journal-title":"Neurocase"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2503-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2503-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2503-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T09:49:34Z","timestamp":1670233774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2503-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":64,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["2503"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2503-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"314"}}